Mechanism of antimetastatic immunopotentiation by low-dose cyclophosphamide

This publication has 21 references indexed in Scilit:

• Effects of TGF-β on the immune system: implications for cancer immunotherapy
  Leukemia, 1999
• REGULATION OF IMMUNE RESPONSES BY TGF-β
  Annual Review of Immunology, 1998
• Published by American Association for the Advancement of Science (AAAS) ,1994
• Transforming Growth Factor‐β CD4⁺ T cells Tumor‐bearing state Immunosuppression Enhanced Production of TGF‐β and a Progressive Increase in TGF‐β Susceptibility of Anti‐tumor CD4⁺ T Cell Function
  Japanese Journal of Cancer Research, 1993
• Suppressor T cells: some answers but more questions
  Immunology Today, 1992
• Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
  The Journal of Experimental Medicine, 1991
• TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties
  Annual Review of Immunology, 1989
• Proliferative and cytolytic potentials of purified human tumor-infiltrating t lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expression
  International Journal of Cancer, 1988
• Some recent advances in the chemistry and biology of transforming growth factor-beta.
  The Journal of cell biology, 1987
• Effect of Cyclophosphamide on Immunological Control Mechanisms
  Immunological Reviews, 1982